Cotadutide vs UBT251

Head-to-head comparison of Cotadutide (MEDI0382, long-acting GLP-1 and glucagon receptor dual agonist) and UBT251 (UBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyCotadutideUBT251
CategoryWeight ManagementWeight Management
Full NameMEDI0382, long-acting GLP-1 and glucagon receptor dual agonistUBT251, glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide/glucagon receptor triagonist
Molecular Weight~4,700 DaN/A
Half-LifeApproximately 24 hoursApproximately 1 week
Amino Acids37N/A
Typical Dose0.3-3 mg daily in clinical studiesInvestigational; no established human dose
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count188
Research StatusClinicalPre-clinical

Cotadutide Benefits

  • body-weight reduction
  • improved insulin sensitivity
  • reduced hepatic fat
  • appetite suppression

UBT251 Benefits

  • weight reduction
  • improved satiety
  • enhanced energy expenditure
  • better insulin sensitivity

Cotadutide Dosing

Once-daily SC in trials|Start low and titrate based on tolerance|Monitor GI adverse effects

UBT251 Dosing

once-weekly subcutaneous injection|dose escalation in studies|maintenance after tolerability assessment

Cotadutide Side Effects

  • nausea
  • vomiting
  • diarrhea

UBT251 Side Effects

  • nausea
  • diarrhea
  • fatigue

Research Overview

Cotadutide

Phase 2 studies reported dose-dependent weight loss and favorable changes in glycemic and liver-related markers. It is one of the most cited synthetic dual-agonist peptides for obesity research.

UBT251

Published work supports strong anti-obesity activity in preclinical models, with translation into human studies still emerging. The compound remains investigational and is best characterized as an early multi-agonist program.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Cotadutide stacks with:

dietary-calorie-restrictionexercise-program

UBT251 stacks with:

metforminorlistat
GLP-1glucagon-coagonistdual-agonistobesity-researchglp1gipglucagontriagonistweight-management